1751 related articles for article (PubMed ID: 20591140)
1. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.
Teede H; Deeks A; Moran L
BMC Med; 2010 Jun; 8():41. PubMed ID: 20591140
[TBL] [Abstract][Full Text] [Related]
2. The role of obesity in the development of polycystic ovary syndrome.
Motta AB
Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
[TBL] [Abstract][Full Text] [Related]
3. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome.
Azziz R; Carmina E; Chen Z; Dunaif A; Laven JS; Legro RS; Lizneva D; Natterson-Horowtiz B; Teede HJ; Yildiz BO
Nat Rev Dis Primers; 2016 Aug; 2():16057. PubMed ID: 27510637
[TBL] [Abstract][Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
8. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
[TBL] [Abstract][Full Text] [Related]
10. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of polycystic ovary syndrome: a practical guide.
Stankiewicz M; Norman R
Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of Polycystic Ovary Syndrome in Adolescents.
Hachey LM; Kroger-Jarvis M; Pavlik-Maus T; Leach R
Nurs Womens Health; 2020 Apr; 24(2):115-126. PubMed ID: 32273076
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
14. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome.
Joham AE; Norman RJ; Stener-Victorin E; Legro RS; Franks S; Moran LJ; Boyle J; Teede HJ
Lancet Diabetes Endocrinol; 2022 Sep; 10(9):668-680. PubMed ID: 35934017
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
17. The impact of obesity on reproduction in women with polycystic ovary syndrome.
Pasquali R; Gambineri A; Pagotto U
BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
20. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS).
Li Y; Chen C; Ma Y; Xiao J; Luo G; Li Y; Wu D
Life Sci; 2019 Jul; 228():167-175. PubMed ID: 31029778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
